Minimal impact of CMV infection on long-term survival after liver transplantation

被引：4

作者：

Seehofer, D

Rayes, N

Steinmüller, T

Schmidt, CA

Settmacher, U

Müller, AR

Neuhaus, P

机构：

[1] Humboldt Univ, Dept Gen Visceral & Transplant Surg, D-13353 Berlin, Germany

[2] Humboldt Univ, Dept Haematol & Oncol, D-13353 Berlin, Germany

来源：

TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 06期

关键词：

D O I：

10.1016/S0041-1345(02)03231-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2272 / 2273

页数：2

共 10 条

[1] Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation [J].

de Otero, J ;

Gavaldà, J ;

Murio, E ;

Vargas, V ;

Calicó, I ;

Llopart, L ;

Rosselló, J ;

Margarit, C ;

Pahissa, A .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :865-870

[2] Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients [J].

Falagas, ME ;

Syndman, DR ;

Griffith, J ;

Ruthazer, R ;

Werner, BG ;

Rohrer, R ;

Freeman, R ;

Fairchild, R ;

Fawaz, K ;

Hoffman, MA ;

Kaplan, M ;

Gill, M ;

Rubin, RH ;

Dienstag, JL ;

Doran, M ;

ORourke, E ;

Vacanti, J ;

Jenkins, R ;

Lewis, WD ;

Hammer, S ;

Martin, M ;

Grady, GF ;

Leszczynski, J ;

Dougherty, N ;

Katz, A ;

Fausett, G ;

Platt, R ;

Cheeseman, SH ;

Pasternack, M ;

Gorbach, SL .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (04) :275-+

[3] Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients [J].

Falagas, ME ;

Snydman, DR ;

Griffith, J ;

Werner, BG ;

Freeman, R ;

Rohrer, R ;

Fairchild, R ;

Fawaz, K ;

Hoffman, MA ;

Kaplan, M ;

Gill, M ;

Rubin, RH ;

Dienstag, JL ;

Doran, M ;

ORourke, E ;

Vacanti, J ;

Jenkins, R ;

Lewis, WD ;

Hammer, S ;

Martin, M ;

Grady, GF ;

Leszczynski, J ;

Dougherty, N ;

Katz, A ;

Fausett, G ;

Platt, R ;

Cheeseman, SH ;

Pasternack, M ;

Gorbach, SL .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (02) :314-317

[4] Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients [J].

Gane, E ;

Saliba, F ;

Valdecasas, GJC ;

OGrady, J ;

Pescovitz, MD ;

Lyman, S ;

Robinson, CA .

LANCET, 1997, 350 (9093) :1729-1733

[5] A MULTIVARIATE-ANALYSIS OF RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS [J].

GORENSEK, MJ ;

CAREY, WD ;

VOGT, D ;

GOORMASTIC, M .

GASTROENTEROLOGY, 1990, 98 (05) :1326-1332

[6] INCIDENCE, DISTRIBUTION, AND OUTCOME OF EPISODES OF INFECTION IN 100 ORTHOTOPIC LIVER TRANSPLANTATIONS [J].

PAYA, CV ;

HERMANS, PE ;

WASHINGTON, JA ;

SMITH, TF ;

ANHALT, JP ;

WIESNER, RH ;

KROM, RAF .

MAYO CLINIC PROCEEDINGS, 1989, 64 (05) :555-564

[7] Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. [J].

Rayes, N ;

Seehofer, D ;

Schmidt, CA ;

Oettle, H ;

Müller, AR ;

Steinmüller, T ;

Settmacher, U ;

Bechstein, WO ;

Neuhaus, P .

TRANSPLANTATION, 2001, 72 (05) :881-885

[8]

Rayes N, 1999, Ann Transplant, V4, P12

[9] COMPARISON OF POLYMERASE CHAIN-REACTION FROM PLASMA AND BUFFY COAT WITH ANTIGEN-DETECTION AND OCCURRENCE OF IMMUNOGLOBULIN-M FOR THE DEMONSTRATION OF CYTOMEGALOVIRUS-INFECTION AFTER LIVER-TRANSPLANTATION [J].

SCHMIDT, CA ;

OETTLE, H ;

PENG, RQ ;

NEUHAUS, P ;

BLUMHARDT, G ;

LOHMANN, R ;

WILBORN, F ;

OSTHOFF, K ;

OERTEL, J ;

TIMM, H ;

SIEGERT, W .

TRANSPLANTATION, 1995, 59 (08) :1133-1138

[10] CYTOMEGALOVIRUS-INFECTION AND DISEASE AFTER LIVER-TRANSPLANTATION - AN OVERVIEW [J].

STRATTA, RJ ;

SHAEFFER, MS ;

MARKIN, RS ;

WOOD, RP ;

LANGNAS, AN ;

REED, EC ;

DONOVAN, JP ;

WOODS, GL ;

BRADSHAW, KA ;

PILLEN, TJ ;

SHAW, BW .

DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (05) :673-688

← 1 →